Published in J Cyst Fibros on October 27, 2004
Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.53
Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab (2009) 1.15
Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr (2011) 1.12
Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev (2009) 0.96
CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells. BMC Med (2014) 0.90
The Peter Pan paradigm. Theor Biol Med Model (2008) 0.88
Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study. Can Respir J (2008) 0.85
Chronic illness and disordered eating: a discussion of the literature. Adv Nutr (2013) 0.84
Pancreatic pathophysiology in cystic fibrosis. J Pathol (2015) 0.79
Fatty diabetic lung: functional impairment in a model of metabolic syndrome. J Appl Physiol (1985) (2010) 0.78
Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol (2013) 0.77
The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes. Sci Rep (2015) 0.77
Noninvasive monitoring of glucose levels: is exhaled breath the answer? J Diabetes Sci Technol (2012) 0.76
Cystic fibrosis-related diabetes in adults: where can we go from here? Rev Diabet Stud (2007) 0.76
Adult cystic fibrosis patients' experiences of primary care consultations: a qualitative study. Br J Gen Pract (2006) 0.75
Characteristics of Patients with Cystic Fibrosis: Experience in a Large Referral Children's Hospital in Tehran, Iran. Middle East J Dig Dis (2010) 0.75
CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells. Sci Rep (2017) 0.75
Acute renal failure in people with cystic fibrosis. Thorax (2007) 0.75
Sputum glucose and glycemic control in cystic fibrosis-related diabetes: a cross-sectional study. PLoS One (2015) 0.75
Islet-intrinsic effects of CFTR mutation. Diabetologia (2016) 0.75
Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med (2004) 3.10
Making medicines evergreen. BMJ (2012) 2.74
Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest (2006) 2.22
Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med (2003) 1.71
Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet (2003) 1.64
Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol (1985) (2007) 1.62
Methodological aspects of bronchoscopic lung volume reduction with a proprietary system. Respiration (2004) 1.43
Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros (2006) 1.30
Cystic fibrosis. Curr Opin Infect Dis (2002) 1.26
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev (2002) 1.17
Effect of hyperglycaemia on glucose concentration of human nasal secretions. Clin Sci (Lond) (2004) 1.16
Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med (2003) 1.13
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax (2013) 1.12
Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism. Pflugers Arch (2008) 1.12
Critical appraisal of the mouse model of myocardial infarction. Exp Physiol (2004) 1.05
Sweet talk: insights into the nature and importance of glucose transport in lung epithelium. Eur Respir J (2012) 1.02
Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch (2008) 1.01
Potential difference measurements in the lower airway of children with and without cystic fibrosis. Am J Respir Crit Care Med (2005) 0.97
Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros (2005) 0.96
Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth. PLoS One (2013) 0.94
The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia. Eur Heart J (2005) 0.94
Proinflammatory mediators disrupt glucose homeostasis in airway surface liquid. J Immunol (2012) 0.93
Bringing new treatments to the bedside in cystic fibrosis. Pediatr Pulmonol (2004) 0.92
Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J Biol Chem (2009) 0.89
COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD (2014) 0.87
Update on gene therapy for cystic fibrosis. Curr Opin Mol Ther (2003) 0.83
The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis. Am J Respir Crit Care Med (2004) 0.83
Bone marrow stem cells do not repopulate the healthy upper respiratory tract. Pediatr Pulmonol (2002) 0.83
Functional MRI demonstrates pain perception in hand osteoarthritis has features of central pain processing. J Biomed Graph Comput (2013) 0.83
Advances in cystic fibrosis gene therapy. Curr Opin Pulm Med (2004) 0.82
Fructose transport-deficient Staphylococcus aureus reveals important role of epithelial glucose transporters in limiting sugar-driven bacterial growth in airway surface liquid. Cell Mol Life Sci (2014) 0.82
Reduction of persistent air leak with endoscopic valve implants. Thorax (2007) 0.82
Blood glucose: of emerging importance in COPD exacerbations. Thorax (2009) 0.82
Endobronchial volume reduction: a myth or a marvel? Semin Respir Crit Care Med (2004) 0.82
The nasal epithelium as a factory for systemic protein delivery. Mol Ther (2002) 0.81
Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis. J Cyst Fibros (2012) 0.81
Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies. Endothelium (2006) 0.80
Safety of Metformin in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus. COPD (2014) 0.80
In vivo imaging of gene transfer to the respiratory tract. Biomaterials (2007) 0.80
Phase II study of tight glycaemic control in COPD patients with exacerbations admitted to the acute medical unit. BMJ Open (2011) 0.79
Biomarkers for cystic fibrosis: are we progressing? Am J Respir Crit Care Med (2007) 0.79
Small chronic pneumothoraces and pulmonary parenchymal abnormalities after bone marrow transplantation. J Thorac Imaging (2007) 0.79
Low-frequency ultrasound increases non-viral gene transfer to the mouse lung. Acta Biochim Biophys Sin (Shanghai) (2010) 0.79
Collateral ventilation and selection of techniques for bronchoscopic lung volume reduction. Thorax (2012) 0.78
Hyperglycaemia in the acute care setting. Clin Med (2012) 0.78
Exploring the mechanisms of macrolides in cystic fibrosis. Respir Med (2005) 0.77
Vascular oligonucleotide transfer facilitated by a polymer-coated stent. Hum Gene Ther (2005) 0.77
Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis. J Cyst Fibros (2006) 0.76
Understanding and managing medication in elderly people. Best Pract Res Clin Obstet Gynaecol (2013) 0.76
A woman with cystic fibrosis, severe hypoxaemia, an atrial thrombus and a patent foramen ovale: a case report. J Med Case Rep (2009) 0.75
Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus. COPD (2015) 0.75
Airway surface liquid calcium modulates chloride permeability in the cystic fibrosis airway. Am J Respir Crit Care Med (2003) 0.75